The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Monkeypox Treatment Market Research Report 2024

Global Monkeypox Treatment Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1764684

No of Pages : 87

Ask Your Query

Synopsis
Monkeypox (mpox) is a viral infection that spreads from animals to humans, hence it is called a zoonotic infection. The recent outbreak of mpox on May 6, 2022. The human mpox virus was initially identified in 1970 in the Democratic Republic of Congo.

The source of the virus is unknown; however, the first six monkeypox cases were found in the UK. Fever, swelling in the lymph nodes, rashes on the skin, chills, muscle fatigue, headache, backache, and respiratory symptoms such as sore throat, cough, and congestion are the common symptoms of monkeypox infection. The virus is transmitted sexually or through touch. The disease has claimed the lives of some people. People with weak immunity, breastfeeding mothers, women during pregnancy, children below the age of 10 years, and people having prolonged exposure to the infected animal are susceptible to the viral infection.

Global Monkeypox Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Monkeypox Treatment market research.

Key companies engaged in the Monkeypox Treatment industry include Bavarian Nordic, Chimerix, Inc., CIDIC Company Limited, Emcure Pharmaceuticals, Emergent, Gilead Sciences Inc., Hetero Drugs Limited, Jinan Jinda Pharmaceutical Chemistry Co. Ltd. and Mylan N.V., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Monkeypox Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Monkeypox Treatment market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Monkeypox Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Bavarian Nordic
  • Chimerix, Inc.
  • CIDIC Company Limited
  • Emcure Pharmaceuticals
  • Emergent
  • Gilead Sciences Inc.
  • Hetero Drugs Limited
  • Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
  • Mylan N.V.
  • Olon S.p.A.
  • Piramal Pharma Solutions
  • SIGA Technologies Inc.
  • Sonofi SA
  • Teva Pharmaceutical Industries Limited

Segment by Type

  • Oral
  • Injectable

Segment by Application

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Monkeypox Treatment report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monkeypox Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injectable
1.3 Market by Application
1.3.1 Global Monkeypox Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monkeypox Treatment Market Perspective (2018-2029)
2.2 Monkeypox Treatment Growth Trends by Region
2.2.1 Global Monkeypox Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Monkeypox Treatment Historic Market Size by Region (2018-2023)
2.2.3 Monkeypox Treatment Forecasted Market Size by Region (2024-2029)
2.3 Monkeypox Treatment Market Dynamics
2.3.1 Monkeypox Treatment Industry Trends
2.3.2 Monkeypox Treatment Market Drivers
2.3.3 Monkeypox Treatment Market Challenges
2.3.4 Monkeypox Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monkeypox Treatment Players by Revenue
3.1.1 Global Top Monkeypox Treatment Players by Revenue (2018-2023)
3.1.2 Global Monkeypox Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Monkeypox Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Monkeypox Treatment Revenue
3.4 Global Monkeypox Treatment Market Concentration Ratio
3.4.1 Global Monkeypox Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monkeypox Treatment Revenue in 2022
3.5 Monkeypox Treatment Key Players Head office and Area Served
3.6 Key Players Monkeypox Treatment Product Solution and Service
3.7 Date of Enter into Monkeypox Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monkeypox Treatment Breakdown Data by Type
4.1 Global Monkeypox Treatment Historic Market Size by Type (2018-2023)
4.2 Global Monkeypox Treatment Forecasted Market Size by Type (2024-2029)
5 Monkeypox Treatment Breakdown Data by Application
5.1 Global Monkeypox Treatment Historic Market Size by Application (2018-2023)
5.2 Global Monkeypox Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Monkeypox Treatment Market Size (2018-2029)
6.2 North America Monkeypox Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Monkeypox Treatment Market Size by Country (2018-2023)
6.4 North America Monkeypox Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monkeypox Treatment Market Size (2018-2029)
7.2 Europe Monkeypox Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Monkeypox Treatment Market Size by Country (2018-2023)
7.4 Europe Monkeypox Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monkeypox Treatment Market Size (2018-2029)
8.2 Asia-Pacific Monkeypox Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Monkeypox Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Monkeypox Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monkeypox Treatment Market Size (2018-2029)
9.2 Latin America Monkeypox Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Monkeypox Treatment Market Size by Country (2018-2023)
9.4 Latin America Monkeypox Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monkeypox Treatment Market Size (2018-2029)
10.2 Middle East & Africa Monkeypox Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Monkeypox Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Monkeypox Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bavarian Nordic
11.1.1 Bavarian Nordic Company Detail
11.1.2 Bavarian Nordic Business Overview
11.1.3 Bavarian Nordic Monkeypox Treatment Introduction
11.1.4 Bavarian Nordic Revenue in Monkeypox Treatment Business (2018-2023)
11.1.5 Bavarian Nordic Recent Development
11.2 Chimerix, Inc.
11.2.1 Chimerix, Inc. Company Detail
11.2.2 Chimerix, Inc. Business Overview
11.2.3 Chimerix, Inc. Monkeypox Treatment Introduction
11.2.4 Chimerix, Inc. Revenue in Monkeypox Treatment Business (2018-2023)
11.2.5 Chimerix, Inc. Recent Development
11.3 CIDIC Company Limited
11.3.1 CIDIC Company Limited Company Detail
11.3.2 CIDIC Company Limited Business Overview
11.3.3 CIDIC Company Limited Monkeypox Treatment Introduction
11.3.4 CIDIC Company Limited Revenue in Monkeypox Treatment Business (2018-2023)
11.3.5 CIDIC Company Limited Recent Development
11.4 Emcure Pharmaceuticals
11.4.1 Emcure Pharmaceuticals Company Detail
11.4.2 Emcure Pharmaceuticals Business Overview
11.4.3 Emcure Pharmaceuticals Monkeypox Treatment Introduction
11.4.4 Emcure Pharmaceuticals Revenue in Monkeypox Treatment Business (2018-2023)
11.4.5 Emcure Pharmaceuticals Recent Development
11.5 Emergent
11.5.1 Emergent Company Detail
11.5.2 Emergent Business Overview
11.5.3 Emergent Monkeypox Treatment Introduction
11.5.4 Emergent Revenue in Monkeypox Treatment Business (2018-2023)
11.5.5 Emergent Recent Development
11.6 Gilead Sciences Inc.
11.6.1 Gilead Sciences Inc. Company Detail
11.6.2 Gilead Sciences Inc. Business Overview
11.6.3 Gilead Sciences Inc. Monkeypox Treatment Introduction
11.6.4 Gilead Sciences Inc. Revenue in Monkeypox Treatment Business (2018-2023)
11.6.5 Gilead Sciences Inc. Recent Development
11.7 Hetero Drugs Limited
11.7.1 Hetero Drugs Limited Company Detail
11.7.2 Hetero Drugs Limited Business Overview
11.7.3 Hetero Drugs Limited Monkeypox Treatment Introduction
11.7.4 Hetero Drugs Limited Revenue in Monkeypox Treatment Business (2018-2023)
11.7.5 Hetero Drugs Limited Recent Development
11.8 Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
11.8.1 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Company Detail
11.8.2 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Business Overview
11.8.3 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Introduction
11.8.4 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Revenue in Monkeypox Treatment Business (2018-2023)
11.8.5 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Recent Development
11.9 Mylan N.V.
11.9.1 Mylan N.V. Company Detail
11.9.2 Mylan N.V. Business Overview
11.9.3 Mylan N.V. Monkeypox Treatment Introduction
11.9.4 Mylan N.V. Revenue in Monkeypox Treatment Business (2018-2023)
11.9.5 Mylan N.V. Recent Development
11.10 Olon S.p.A.
11.10.1 Olon S.p.A. Company Detail
11.10.2 Olon S.p.A. Business Overview
11.10.3 Olon S.p.A. Monkeypox Treatment Introduction
11.10.4 Olon S.p.A. Revenue in Monkeypox Treatment Business (2018-2023)
11.10.5 Olon S.p.A. Recent Development
11.11 Piramal Pharma Solutions
11.11.1 Piramal Pharma Solutions Company Detail
11.11.2 Piramal Pharma Solutions Business Overview
11.11.3 Piramal Pharma Solutions Monkeypox Treatment Introduction
11.11.4 Piramal Pharma Solutions Revenue in Monkeypox Treatment Business (2018-2023)
11.11.5 Piramal Pharma Solutions Recent Development
11.12 SIGA Technologies Inc.
11.12.1 SIGA Technologies Inc. Company Detail
11.12.2 SIGA Technologies Inc. Business Overview
11.12.3 SIGA Technologies Inc. Monkeypox Treatment Introduction
11.12.4 SIGA Technologies Inc. Revenue in Monkeypox Treatment Business (2018-2023)
11.12.5 SIGA Technologies Inc. Recent Development
11.13 Sonofi SA
11.13.1 Sonofi SA Company Detail
11.13.2 Sonofi SA Business Overview
11.13.3 Sonofi SA Monkeypox Treatment Introduction
11.13.4 Sonofi SA Revenue in Monkeypox Treatment Business (2018-2023)
11.13.5 Sonofi SA Recent Development
11.14 Teva Pharmaceutical Industries Limited
11.14.1 Teva Pharmaceutical Industries Limited Company Detail
11.14.2 Teva Pharmaceutical Industries Limited Business Overview
11.14.3 Teva Pharmaceutical Industries Limited Monkeypox Treatment Introduction
11.14.4 Teva Pharmaceutical Industries Limited Revenue in Monkeypox Treatment Business (2018-2023)
11.14.5 Teva Pharmaceutical Industries Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock